Zhang Y, Wu YF, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Wang T, Liu FQ. Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus. World J Gastrointest Oncol 2019; 11(4): 310-321 [PMID: 31040896 DOI: 10.4251/wjgo.v11.i4.310]
Corresponding Author of This Article
Fu-Quan Liu, BCPS, MD, Professor, Department of Interventional Therapy, Peking University Ninth School of Clinical Medicine, Beijing Shijitan Hospital and Capital Medical University, No. 10 Tie Yi Road, Yangfangdian, Haidian District, Beijing 100010, China. lfuquan@aliyun.com
Research Domain of This Article
Oncology
Article-Type of This Article
Retrospective Cohort Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Oncol. Apr 15, 2019; 11(4): 310-321 Published online Apr 15, 2019. doi: 10.4251/wjgo.v11.i4.310
Table 1 Baseline characteristics on patients
TIPS-125I group(n = 40)
TIPS only group(n = 45)
P-value
Gender
0.961
Male
27
30
Female
13
15
Average age
51 ± 4.3
49 ± 6.9
0.311
Etiology
0.923
Hepatitis B or C
24
28
Alcoholic
8
7
Cholestasis
4
6
Other
4
4
Child-Push classification
0.384
A
6
10
B
20
16
C
14
19
Albumin (g/L)
30 ± 11
32 ± 11
0.915
Direct bilirubin (umol/L)
23.1 ± 16.9
21 ± 15
0.43
Alanine aminotransferase (U/L)
49 ± 36
53 ± 41
0.756
Aspartate aminotransferase (U/L)
42.5 ± 26.5
50.5 ± 37.5
0.318
Na+
135.5 ± 15.5
138.5 ± 16.5
0.384
K+
3.73 ± 1.27
3.49 ± 1.31
0.609
MELD score
11.96 ± 1.68
12.77 ± 2.49
0.187
Clinical symptoms
0.486
Hemorrhage
29
32
Chest and/or abdominal dropsy
6
5
Both
5
8
First-grade branch of portal vein
0.571
Unobstructed
18
22
Obstructed
22
23
Table 2 The portosystemic pressure gradient before and after transjugular intrahepatic portosystemic shunt was significantly different in the two groups
PPG before TIPS (mmHg)
PPG after TIPS (mmHg)
Number
t
df
P-value
SD of difference
SEM of difference
R squared
TIPS-125I group
26.96 ± 5.73
13.1 ± 5.9
40
20.88
39
< 0.0001
4.367
0.6905
0.9179
TIPS only group
26.12 ± 5
12.6 ± 5.4
45
22.94
44
0.0002
4.089
0.6096
0.9228
Table 3 The rates of symptom recurrence, stent restenosis and survival during follow-up
TIPS-125I group
TIPS only group
P-value
Rate of stent stenosis
< 0.05
6 mo
12.5
42.2
12 mo
27.5
68.9
24 mo
42.5
84.4
Rate of symptom recurrence
< 0.05
6 mo
7.5
31.1
12 mo
22.5
62.2
24 mo
35
82.2
Survival rate
< 0.05
6 mo
80
64.4
12 mo
45
24.4
24 mo
20
4.4
Table 4 The multivariate analysis of survival
Univariate analysis
Multivariate analysis
HR
95%CI
P-value
HR
95%CI
P-value
Group
1.943
1.219-3.097
0.005
2.631
1.603-4.318
< 0.001
MELD score
1.042
0.849-1.279
0.692
1.697
1.261-2.282
< 0.001
DBIL
0.988
0.965-1.012
0.338
0.161
ALT
0.991
0.979-1.003
0.150
0.078
Child-Pugh classification
< 0.001
< 0.001
B/A
1.546
0.793-3.016
0.201
3.783
1.718-8.329
C/A
3.493
1.764-6.918
< 0.001
13.87
5.192-37.07
Citation: Zhang Y, Wu YF, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Wang T, Liu FQ. Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus. World J Gastrointest Oncol 2019; 11(4): 310-321